Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival. (3rd April 2022)
- Record Type:
- Journal Article
- Title:
- Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival. (3rd April 2022)
- Main Title:
- Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival
- Authors:
- Kharoubi, Mounira
Bodez, Diane
Bézard, Mélanie
Zaroui, Amira
Galat, Arnault
Guendouz, Soulef
Gendre, Thierry
Hittinger, Luc
Attias, David
Mohty, Dania
Bergoend, Eric
Itti, Emmanuel
Lebras, Fabien
Hamon, David
Poullot, Elsa
Molinier-Frenkel, Valérie
Lellouche, Nicolas
Deux, Jean-François
Funalot, Benoit
Fannen, Pascale
Oghina, Silvia
Arrouasse, Raphael
Lecorvoisier, Philippe
Souvannanorath, Sarah
Amiot, Aurelien
Teiger, Emmanuel
Bougouin, Wulfran
Damy, Thibaud - Abstract:
- Abstract: Background: The three main cardiac amyloidosis (CA) types have different progression and prognosis. Little is known about the mode of death (MOD) which is commonly attributed to cardiovascular causes in CA. Improving MOD's knowledge could allow to adapt patient care. Objective: This retrospective study describes the MOD that occurred during long-term follow-up in CA patients in light-chain (AL), transthyretin hereditary (ATTRv) or wild-type (ATTRwt). Material and methods: Patients referred to and cared for, at the French referral centre for CA, Henri Mondor Hospital, Créteil between 2010 and 2016 were included. Clinical information surrounding patient deaths were investigated and centrally evaluated by two blinded clinical committees which classified MOD as cardiovascular, non-cardiovascular or unknown and sub-classified it depending on its subtype. Results: From the 566 patients included, 187 had AL, 206 ATTRv and 173 ATTRwt. During the 864 patient-year follow-up, 160 (28%) deaths occurred, with median survival time of 17.3 months (interquartile range 5.1–35.4). The most frequent MOD was cardiovascular (64%) of which worsening heart failure occurred most frequently and for which, 69% were of AL subtype, 79% ATTRv and 76% ATTRwt. Sudden death also occurred more frequently in AL subtype accounting for 29% of AL deaths. Non-cardiovascular MOD occurred in 26% of patients overall. Among these, infection was the most common non-cardiovascular MOD in any type of CAAbstract: Background: The three main cardiac amyloidosis (CA) types have different progression and prognosis. Little is known about the mode of death (MOD) which is commonly attributed to cardiovascular causes in CA. Improving MOD's knowledge could allow to adapt patient care. Objective: This retrospective study describes the MOD that occurred during long-term follow-up in CA patients in light-chain (AL), transthyretin hereditary (ATTRv) or wild-type (ATTRwt). Material and methods: Patients referred to and cared for, at the French referral centre for CA, Henri Mondor Hospital, Créteil between 2010 and 2016 were included. Clinical information surrounding patient deaths were investigated and centrally evaluated by two blinded clinical committees which classified MOD as cardiovascular, non-cardiovascular or unknown and sub-classified it depending on its subtype. Results: From the 566 patients included, 187 had AL, 206 ATTRv and 173 ATTRwt. During the 864 patient-year follow-up, 160 (28%) deaths occurred, with median survival time of 17.3 months (interquartile range 5.1–35.4). The most frequent MOD was cardiovascular (64%) of which worsening heart failure occurred most frequently and for which, 69% were of AL subtype, 79% ATTRv and 76% ATTRwt. Sudden death also occurred more frequently in AL subtype accounting for 29% of AL deaths. Non-cardiovascular MOD occurred in 26% of patients overall. Among these, infection was the most common non-cardiovascular MOD in any type of CA (80%). Conclusions: Mortality is high during natural course of CA and differs between subtypes. The main MOD were worsening heart failure, sudden death and infection, opening room to optimise management. … (more)
- Is Part Of:
- Amyloid. Volume 29:Number 2(2022)
- Journal:
- Amyloid
- Issue:
- Volume 29:Number 2(2022)
- Issue Display:
- Volume 29, Issue 2 (2022)
- Year:
- 2022
- Volume:
- 29
- Issue:
- 2
- Issue Sort Value:
- 2022-0029-0002-0000
- Page Start:
- 79
- Page End:
- 91
- Publication Date:
- 2022-04-03
- Subjects:
- Mode of death -- light-chain -- transthyretin hereditary -- wild-type cardiac amyloidosis
Amyloidosis -- Periodicals
616.3995 - Journal URLs:
- http://informahealthcare.com/loi/amy ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/13506129.2021.2013193 ↗
- Languages:
- English
- ISSNs:
- 1350-6129
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0859.841173
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 22096.xml